loader2
Login Open ICICI 3-in-1 Account

Jan 13, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 40.01 9.37 15.04 38.96 0.04 44.95 35.66
Cipla Ltd 21.79 4.30 3.60 16.92 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 40.92 7.50 7.71 29.12 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 17.68 3.11 2.82 12.49 0.11 23.05 18.53
Lupin Ltd 23.01 4.41 5.09 19.29 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 62.44 11.60 15.82 41.56 0.50 25.84 26.46
Ipca Laboratories Ltd 45.42 4.34 5.22 26.44 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 39.74 7.93 5.35 26.98 0.04 19.52 16.16
Aurobindo Pharma Ltd 19.91 2.15 1.94 11.23 0.24 14.16 11.15
Wockhardt Ltd -444.04 7.52 4.96 79.96 0.57 3.87 -1.48
Ajanta Pharma Ltd 35.08 7.35 7.90 26.60 0.01 31.98 25.02
Gland Pharma Ltd 35.51 5.00 2.93 18.70 0.00 15.83 11.62
Biocon Ltd 73.53 3.68 1.66 20.63 0.84 6.86 6.90
Alkem Laboratories Ltd 29.11 5.41 5.26 28.63 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 56.41 4.28 5.94 32.15 0.22 18.48 15.79
Zydus Lifesciences Ltd 17.91 3.87 3.56 12.41 0.09 24.56 21.08
Divis Laboratories Ltd 69.31 18.40 11.17 57.16 0.00 20.42 15.35
Mankind Pharma Ltd 51.82 7.53 6.01 34.13 0.37 16.04 14.83
Laurus Labs Ltd 82.53 10.13 11.72 57.42 0.62 8.80 7.36
Piramal Pharma Ltd -932.50 2.44 2.76 22.39 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 69003.0
(0.4424%)
70833.65 56192.45
Nifty Bank 59678.95
(0.3843%)
60437.35 47702.90
Nifty 50 25846.25
(0.2171%)
26373.20 21743.65
Nifty 100 26423.50
(0.2508%)
26975.15 22177.35
BSE SmallCap 49805.72
(0.4679%)
55792.26 41013.68
BSE Sensex 83781.25
(-0.1155%)
86159.02 71425.01
BSE MidCap 46156.52
(0.0867%)
47764.30 37203.21
BSE 100 26976.69
(-0.0859%)
27621.72 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

NLC India fixes record date for interim dividend

NLC India has fixed 16 January 2026 as record date for the purpose of ascertaining the members entitled f...

Jan 12, 2026 19:10
TCS fixes record date for 3rd interim dividend and special dividend

Tata Consultancy Services has fixed 17 January 2026 as record date for payment of third interim dividend ...

Jan 12, 2026 16:48
NSE in talks with IGX to launch Indian Natural Gas Futures

National Stock Exchange of India is in talks with Indian Gas Exchange to develop and launch an Indian Nat...

Jan 09, 2026 10:53
Havells India fixes record date for interim dividend

Havells India has fixed 23 January 2026 as record date to determine the entitlement of interim dividend, ...

Jan 08, 2026 12:44
Jonjua Overseas fixes record date for bonus issue

Jonjua Overseas has fixed 23 January 2026 as record date for allotment of bonus equity shares. Further ...

Jan 07, 2026 09:36
Energy Infrastructure Trust fixes record date for payment of distribution

Energy Infrastructure Trust has fixed 09 January 2026 as record date for payment of distribution of Rs 3....

Jan 06, 2026 12:07
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.